Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial

By Albrecht D.M.  

Clinical Drug Investigation, Vol. 24, Iss. 3, 2004-01 ,pp. : 137-147

Adis International

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite

Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats

By de la Cruz J.P.   Moreno A.   Ruiz-Ruiz M.I.   Garca-Campos J.   Sanchez de la Cuesta F.  

European Journal of Pharmacology, Vol. 360, Iss. 1, 1998-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite